| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
2 companies
Emily Luisa Hill is Chief Financial Officer at REPL, with reported holdings spanning 2 companies. From January 2020 to August 2026, the filings on record show 0 open-market purchases and 23 sales. Emily Luisa Hill's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.1M at current prices.
Our model assigns Emily Luisa Hill a middling insider score of 59/100, based on 15 past trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +10.8%.
Emily Luisa Hill's largest disclosed position is in REPL as Chief Financial Officer, worth about $4.5M. The REPL filings lean toward selling, a net 49,143 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 758 | $41.66 | $31,575.40 | -1.6% | +16.9% | -31.0% | |
| Mar 31, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 7,910 | $37.78 | $298,823.98 | -21.3% | +8.3% | +29.8% | |
| Feb 1, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 553 | $40.00 | $22,121.11 | -1.5% | -10.7% | +16.9% | |
| Jan 25, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 211 | $39.31 | $8,295.25 | -0.6% | +2.6% | +18.4% | |
| Jan 7, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 800 | $38.53 | $30,820.00 | -3.5% | +12.9% | +3.2% | |
| Jan 4, 2022 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 173 | $41.16 | $7,121.03 | -0.7% | +5.9% | -3.4% | |
| Feb 1, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 541 | $56.96 | $30,813.20 | -2.3% | - | - | |
| Jan 25, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 275 | $62.05 | $17,064.85 | -1.1% | - | - | |
| Jan 8, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 26,033 | $69.75 | $1,815,801.75 | -51.9% | - | - | |
| Jan 5, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Financial Officer | Sell | 288 | $62.37 | $17,962.56 | -2.1% | - | - |